Epidermal growth factor (EGF), oral spray vs placebo
Oral mucositis (severe) · Adults with cancer receiving treatment
Epidermal growth factor (EGF), oral spray showed no clear difference in oral mucositis (severe) compared with placebo; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesChemoradiotherapy to the head and neckRR 1.03 [0.59, 1.80]1 study · 136 participantsGRADE not reported